S100P and infantile convulsions and choreoathetosis: Taken together, these results indicate that S100P and SPP1 are two optimal biomarkers for distinguishing iCCAphl and iCCApps, which can effectively divide the iCCA patients into two subtypes with different cell origins and clinicopathological characteristics.